Strategic partnerships Target Precision Biologics for collaboration opportunities in tumor-specific glycans, antibody-drug conjugates, and AML therapies, leveraging their preclinical to clinical focus and leadership.

Clinical pipeline Explore opportunities to provide contract research, specialized assays, or CRO services around preclinical ADCs and AML targets presented at AACR and SITC conferences.

Funding leverage Position specialized clinical development services, regulatory strategy support, and milestone-based partnerships to align with their $59M funding and revenue scale.

Strategic customers Offer scalable manufacturing, analytical development, or process optimization services tailored for small biotech with AML and ovarian cancer targets to help accelerate trials.

Market visibility Propose co-marketing or advisory roles for events and speaker engagements to extend their reach at AACR, SITC, and related conferences, generating mutual exposure and pipeline opportunities.